Michael Petusky
Stock Analyst at Barrington Research
(1.99)
# 3,106
Out of 4,966 analysts
196
Total ratings
36.56%
Success rate
-7.85%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRME VerifyMe | Maintains: Outperform | $1.25 → $1.5 | $0.89 | +68.50% | 10 | Aug 14, 2025 | |
| SRDX Surmodics | Reiterates: Market Perform | n/a | $34.04 | - | 7 | Aug 11, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $21 → $18 | $14.30 | +25.87% | 23 | Aug 8, 2025 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $98 → $103 | $82.89 | +24.26% | 24 | Aug 8, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $95 → $86 | $54.54 | +57.68% | 30 | Aug 8, 2025 | |
| LMAT LeMaitre Vascular | Upgrades: Outperform | $95 | $95.37 | -0.38% | 11 | Aug 6, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $86 → $78 | $69.58 | +12.10% | 15 | Aug 6, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $103 | $90.54 | +13.76% | 21 | Jul 31, 2025 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $19 → $15 | $9.38 | +59.91% | 18 | Jul 31, 2025 | |
| OPCH Option Care Health | Maintains: Outperform | $38 | $28.68 | +32.50% | 16 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $14.98 | +6.81% | 1 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $2.25 | $1.38 | +63.04% | 14 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.61 | - | 6 | Aug 28, 2024 |
VerifyMe
Aug 14, 2025
Maintains: Outperform
Price Target: $1.25 → $1.5
Current: $0.89
Upside: +68.50%
Surmodics
Aug 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $34.04
Upside: -
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Outperform
Price Target: $21 → $18
Current: $14.30
Upside: +25.87%
U.S. Physical Therapy
Aug 8, 2025
Maintains: Outperform
Price Target: $98 → $103
Current: $82.89
Upside: +24.26%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $95 → $86
Current: $54.54
Upside: +57.68%
LeMaitre Vascular
Aug 6, 2025
Upgrades: Outperform
Price Target: $95
Current: $95.37
Upside: -0.38%
Henry Schein
Aug 6, 2025
Maintains: Outperform
Price Target: $86 → $78
Current: $69.58
Upside: +12.10%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $103
Current: $90.54
Upside: +13.76%
Anika Therapeutics
Jul 31, 2025
Maintains: Outperform
Price Target: $19 → $15
Current: $9.38
Upside: +59.91%
Option Care Health
Jul 10, 2025
Maintains: Outperform
Price Target: $38
Current: $28.68
Upside: +32.50%
Jun 23, 2025
Initiates: Outperform
Price Target: $16
Current: $14.98
Upside: +6.81%
May 1, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.38
Upside: +63.04%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $7.61
Upside: -